Metraipolis › archive › dc_deaeac29371d

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and Surveillance — Europe PMC PMID:41228219

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228219
DOI
10.3390/cancers17213425
License (as archived)
solo-consultazione
Archived
2026-11-09T01:38:10.226Z
SHA-256 of the archived text
4c2613e373e8eb6cb846e7e4550f7c3709d254c57afca0cb5519cace4f705eeb
Stable URL of this page
https://metraipolis.com/documento/dc_deaeac29371d

How to cite

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and Surveillance — Europe PMC PMID:41228219 — Europe PMC (en), https://europepmc.org/article/MED/41228219 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_deaeac29371d (Metraipolis archive dc_deaeac29371d, sha256 4c2613e373e8eb6cb846e7e4550f7c3709d254c57afca0cb5519cace4f705eeb)
BibTeX
@misc{dcdeaeac29371d,
  title = {Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and Surveillance — Europe PMC PMID:41228219},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228219},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_deaeac29371d; sha256 4c2613e373e8eb6cb846e7e4550f7c3709d254c57afca0cb5519cace4f705eeb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228219. Agents can read the archived copy with the MCP tool read_document.